Abstract

BackgroundB-cell depletion is a fundamental effect of rituximab (RTX). The speed/depth of initial B-cell depletion is associated with clinical response, and non-responders largely having incomplete depletion.1 2 However, some patients...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call